(Q51007354)

26 March 2018

title

Serial changes in adipocytokines and cardiac function in a rat model of the metabolic syndrome. (English)

1 reference

26 March 2018

1 reference

Takanori Yamaguchi

1

1 reference

26 March 2018

Kazuya Kitamori

2

1 reference

26 March 2018

Gaku Ichihara

3

1 reference

26 March 2018

Yuka Suzuki

4

1 reference

26 March 2018

Miyuki Ochiai

5

1 reference

26 March 2018

Yoshiji Yamada

6

1 reference

26 March 2018

Saeko Tada-Oikawa

7

1 reference

26 March 2018

Satoru Tsuchikura

8

1 reference

26 March 2018

Yukio Yamori

9

1 reference

26 March 2018

Sahoko Ichihara

10

1 reference

26 March 2018

publication date

1 July 2013

1 reference

26 March 2018

Clinical and Experimental Pharmacology and Physiology

published in

1 reference

26 March 2018

volume

40

1 reference

26 March 2018

issue

7

1 reference

26 March 2018

page(s)

443-448

1 reference

26 March 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Adiponectin and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

PGC-1α mRNA level and oxidative capacity of the plantaris muscle in rats with metabolic syndrome, hypertension, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

The Lou/C rat: a model of spontaneous food restriction associated with improved insulin sensitivity and decreased lipid storage in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Insulin resistance and risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Adiponectin is synthesized and secreted by human and murine cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Hyperinsulinemia induces insulin resistance on glucose and lipid metabolism in a human adipocytic cell line: paracrine interaction with myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Serum resistin is associated with high risk in patients with congestive heart failure--a novel link between metabolic signals and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: Relationship with abdominal fat deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12107

21 January 2018

Identifiers

DOI

10.1111/1440-1681.12107

1 reference

26 March 2018

PubMed ID

23659633

1 reference

26 March 2018